In line with Vajira Hospital's drive to provide reliable healthcare support for patients at home, these initiatives will include a cold chain delivery of selected temperature-controlled medicines and a home injection service administered by qualified nurses.
Assoc. Prof. Dr. Mason Poramatikul, Assistant Dean of the Faculty of Medicine Vajira Hospital said that these initiatives will cover end-to-end services for osteoporotic patients, including temperature-controlled cold-chain delivery and nurse-administered injections of treatments at home.
He added that Vajira Hospital is one of the first in Thailand to launch these services catering to the needs of the elderly patients who have difficulties leaving their homes to seek treatment. Supported by well-designed care processes and high standards, the initiatives aim to provide the patients with convenience and quality care from the safety of their homes.
Ms Pattaraporn Vimonwatvetee, General Manager, Amgen (Thailand) said the company is committed to supporting osteoporosis patients and is delighted to partner with Vajira Hospital. These initiatives will enable patients to continue receiving treatments and care support that will help maintain their health and well-being while staying safely at home. The company will be working with Zuellig Pharma Co, Ltd, a leading pharmaceutical distributor on the logistics.
In addition to these home-based care initiatives, Vajira Hospital also recently launched the "[email protected] - Far but Near, From Hospital to your Home" mobile application which enables patients to access to a wide range of services offered by the hospital. For more information, please visit
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
Source: Core and Peak